The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?

Andreas Carus; Karin Holmsten; Helle Pappot; Anders Ullén

doi:10.1080/0284186X.2022.2153620

The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?

Andreas Carus^*, Karin Holmsten, Helle Pappot, Anders Ullén

^*Corresponding author af dette arbejde

Afdeling for Kræftbehandling

Originalsprog	Engelsk
Tidsskrift	Acta Oncologica
Vol/bind	61
Udgave nummer	12
Sider (fra-til)	1515-1516
Antal sider	2
ISSN	0284-186X
DOI	https://doi.org/10.1080/0284186X.2022.2153620
Status	Udgivet - dec. 2022

Adgang til dokumentet

10.1080/0284186X.2022.2153620

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{d8679a6d772d4cf0b76fd130d82e172e,

title = "The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?",

keywords = "Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Chemotherapy, Adjuvant, Cisplatin/therapeutic use, Humans, Muscles, Neoadjuvant Therapy, Neoplasm Invasiveness, Treatment Outcome, Urinary Bladder Neoplasms/drug therapy",

author = "Andreas Carus and Karin Holmsten and Helle Pappot and Anders Ull{\'e}n",

year = "2022",

month = dec,

doi = "10.1080/0284186X.2022.2153620",

language = "English",

volume = "61",

pages = "1515--1516",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Informa Healthcare",

number = "12",

}

TY - JOUR

T1 - The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer

T2 - still an open question?

AU - Carus, Andreas

AU - Holmsten, Karin

AU - Pappot, Helle

AU - Ullén, Anders

PY - 2022/12

Y1 - 2022/12

KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use

KW - Chemotherapy, Adjuvant

KW - Cisplatin/therapeutic use

KW - Humans

KW - Muscles

KW - Neoadjuvant Therapy

KW - Neoplasm Invasiveness

KW - Treatment Outcome

KW - Urinary Bladder Neoplasms/drug therapy

UR - http://www.scopus.com/inward/record.url?scp=85144208551&partnerID=8YFLogxK

U2 - 10.1080/0284186X.2022.2153620

DO - 10.1080/0284186X.2022.2153620

M3 - Letter

C2 - 36484326

SN - 0284-186X

VL - 61

SP - 1515

EP - 1516

JO - Acta Oncologica

JF - Acta Oncologica

IS - 12

ER -